Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

IsoRay Inc. (ISR)

0.3881   -0 (-0.1%) 11-19 16:00
Open: 0.38 Pre. Close: 0.3885
High: 0.398 Low: 0.3712
Volume: 222,373 Market Cap: 26M
IsoRay Inc designs and develops personalized brachytherapy products. The company treats prostate cancer, brain, liver, breast cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.391 - 0.393 0.393 - 0.394
Low: 0.366 - 0.368 0.368 - 0.369
Close: 0.387 - 0.39 0.39 - 0.393

Technical analysis

as of: 2019-11-19 4:27:27 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 0.49     One year: 0.57
Support: Support1: 0.34    Support2: 0.29
Resistance: Resistance1: 0.42    Resistance2: 0.49
Pivot: 0.35
Moving Average: MA(5): 0.39     MA(20): 0.34
MA(100): 0.35     MA(250): 0.38
MACD: MACD(12,26): 0.02     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 74.47     %D(3): 73.33
RSI: RSI(14): 67.67
52-week: High: 0.50  Low: 0.27  Change(%): -3.0
Average Vol(K): 3-Month: 16769  10-Days: 30732

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ISR has closed below upper band by 15.7%. Bollinger Bands are 89.9% wider than normal. The large width of the bands suggest high volatility as compared to ISR's normal range. The bands have been in this wide range for 3 bars. This is a sign that the current trend might continue.

Headline News

IsoRay (ISR) Upgraded to Buy: Here's What You Should Know
IsoRay (ISR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

IsoRay, Inc. (ISR) CEO Lori Woods on Q3 2019 Results - Earnings Call Transcript
No summary available.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Medical Instruments Supplies
Shares Out. (M) 67.39
Shares Float (M) 66.97
% Held by Insiders 0.99
% Held by Institutions 8.64
Shares Short (K) 1370
Shares Short P. Month (K)

Stock Financials

EPS -0.077
Book Value (p.s.) 0.110
PEG Ratio
Profit Margin -70.33
Operating Margin -72.16
Return on Assets (ttm) -39.1
Return on Equity (ttm) -80.9
Qtrly Rev. Growth 20.0
Gross Profit (p.s.) 0.045
Sales Per Share
EBITDA (p.s.) -0.075
Qtrly Earnings Growth
Operating Cash Flow (M) -5.05
Levered Free Cash Flow (M) -3.79

Stock Valuations

P/E -5.04
P/E Growth Ratio
P/BV 3.53
P/S 3.52
P/CF -5.18

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.